Coverart for item
The Resource Cancer biomarkers : minimal and noninvasive early diagnosis and prognosis, edited by Debmalya Barh, Angelo Carpi, Mukesh Verma, Mehmet Gunduz

Cancer biomarkers : minimal and noninvasive early diagnosis and prognosis, edited by Debmalya Barh, Angelo Carpi, Mukesh Verma, Mehmet Gunduz

Label
Cancer biomarkers : minimal and noninvasive early diagnosis and prognosis
Title
Cancer biomarkers
Title remainder
minimal and noninvasive early diagnosis and prognosis
Statement of responsibility
edited by Debmalya Barh, Angelo Carpi, Mukesh Verma, Mehmet Gunduz
Creator
Contributor
Editor
Subject
Language
eng
Summary
"According to the American Cancer Society report, "by 2030, the global cancer burden is expected to nearly double, growing to 21.4 million cases and 13.2 million deaths." Early diagnosis improves treatment efficacy and quality of life as well as reduces the cost for disease management. However, the development of molecular markers for early cancer diagnosis is always a challenge. Some fundamental principles in medical practice are (a) primum non nocere, a Latin phrase that means "first, do no harm," and (b) even when a patient's prognosis is poor, the physician must do his or her best for improving quality of the patient's life. Therefore, noninvasive or minimally invasive cancer diagnostic methods are of choice that can avoid complications of biopsy and other unfavorable impacts on patient's health. In this context, patients' easily collectable biospecimens such as blood, serum, plasma, urine, stool, sputum, saliva, etc.-based molecular markers having high specificity and sensitivity in early diagnosis are emerging rapidly and in many instances such markers are also emerging as next-generation prognostic indicators and personalized therapeutics and precision medicine. Several patents have been filed and/or granted on such markers, and a number of health-care companies and authorities currently use or focus on the development of such markers. The significance of clinical validation approaches of several markers has been discussed in different chapters. This book, Cancer Biomarkers: Noninvasive Early Diagnosis and Prognosis, reflects the rapid expansion of important scientific, technological, clinical, and translational aspects of noninvasive or minimally invasive molecular cancer biomarkers and their applications along with other conventional markers"--Provided by publisher
Cataloging source
E7B
http://bibfra.me/vocab/lite/collectionName
Cancer biomarkers (Barh)
Dewey number
616.99/4
Illustrations
illustrations
Index
no index present
LC call number
RC270.3.T84
LC item number
C36 2014eb
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
QZ 241
http://library.link/vocab/relatedWorkOrContributorName
  • Barh, Debmalya
  • Carpi, A.
  • Verma, Mukesh
  • Gunduz, Mehmet
http://library.link/vocab/subjectName
  • Tumor markers
  • Cancer
  • Cancer
  • Biomarkers, Tumor
  • Early Detection of Cancer
  • Neoplasms
  • Neoplasms
  • HEALTH & FITNESS
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • Cancer
  • Cancer
  • Tumor markers
Label
Cancer biomarkers : minimal and noninvasive early diagnosis and prognosis, edited by Debmalya Barh, Angelo Carpi, Mukesh Verma, Mehmet Gunduz
Instantiates
Publication
Copyright
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Part I. General and technical aspects. Quality control and ethical issues of cancer biomarker discovery -- Imaging techniques in cancer diagnosis -- Role of pet in cancer diagnosis -- Innovative tools for early detection of cancer -- Noninvasive nanodiagnostics for cancer -- Mitochondrial DNA in early cancer diagnosis and screening -- Circulating miRNA biomarkers in various solid cancers -- Stem cell biomarkers in early diagnosis, prognosis, and therapy of cancer -- Salivary biomarkers in early diagnosis and monitoring of cancer -- Part II. Brain and head and neck cancers. Biomarkers for brain gliomas -- Noninvasive biomarkers in head and neck squamous cell carcinoma -- Biological markers in oral squamous cell carcinoma -- Part III. Gastrointestinal cancers. Biomarkers for gastric cancer and the related premalignant conditions -- Biomarkers in esophageal adenocarcinoma -- Biomarkers for diagnosis and metastasis of hepatocellular carcinoma -- Noninvasive early markers in gallbladder cancer -- Noninvasive early markers in pancreatic cancer -- Part IV. Lung cancer and mesothelioma. Noninvasive early markers in lung cancer -- Exhaled volatile organic compounds as noninvasive early molecular markers in lung cancer: bridging the gap from bench to bedside -- Part V. Urological cancers. Noninvasive early molecular biomarkers in kidney cancer -- Novel oncomarkers used for earlier detection of bladder carcinoma -- Screening for prostate cancer: new markers and future aspects -- Part VI. Gynecological and endocrine cancers. Early biomarkers in breast cancer -- Noninvasive biomarkers in ovarian cancer -- Early markers for neoplastic lesions of the uterine cervix -- Biomarkers in diagnosis of papillary thyroid carcinoma -- Biomolecular markers for improving management of follicular and medullary thyroid cancer -- Part VII. Hematological cancers. Biomarkers in myelodysplastic syndrome -- Markers for diagnosis, prognosis, and therapy of acute myeloid leukemia -- Biomarkers in Hodgkin's lymphoma -- Multiple myeloma and evolution of novel biomarkers and therapies -- Part VIII. Melanoma. Diagnostic and prognostic biomarkers in cutaneous melanoma
Control code
868928126
Extent
1 online resource (954 pages)
Form of item
online
Isbn
9781466584297
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
Specific material designation
remote
System control number
  • (OCoLC)868928126
  • ebr10821667
Label
Cancer biomarkers : minimal and noninvasive early diagnosis and prognosis, edited by Debmalya Barh, Angelo Carpi, Mukesh Verma, Mehmet Gunduz
Publication
Copyright
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Part I. General and technical aspects. Quality control and ethical issues of cancer biomarker discovery -- Imaging techniques in cancer diagnosis -- Role of pet in cancer diagnosis -- Innovative tools for early detection of cancer -- Noninvasive nanodiagnostics for cancer -- Mitochondrial DNA in early cancer diagnosis and screening -- Circulating miRNA biomarkers in various solid cancers -- Stem cell biomarkers in early diagnosis, prognosis, and therapy of cancer -- Salivary biomarkers in early diagnosis and monitoring of cancer -- Part II. Brain and head and neck cancers. Biomarkers for brain gliomas -- Noninvasive biomarkers in head and neck squamous cell carcinoma -- Biological markers in oral squamous cell carcinoma -- Part III. Gastrointestinal cancers. Biomarkers for gastric cancer and the related premalignant conditions -- Biomarkers in esophageal adenocarcinoma -- Biomarkers for diagnosis and metastasis of hepatocellular carcinoma -- Noninvasive early markers in gallbladder cancer -- Noninvasive early markers in pancreatic cancer -- Part IV. Lung cancer and mesothelioma. Noninvasive early markers in lung cancer -- Exhaled volatile organic compounds as noninvasive early molecular markers in lung cancer: bridging the gap from bench to bedside -- Part V. Urological cancers. Noninvasive early molecular biomarkers in kidney cancer -- Novel oncomarkers used for earlier detection of bladder carcinoma -- Screening for prostate cancer: new markers and future aspects -- Part VI. Gynecological and endocrine cancers. Early biomarkers in breast cancer -- Noninvasive biomarkers in ovarian cancer -- Early markers for neoplastic lesions of the uterine cervix -- Biomarkers in diagnosis of papillary thyroid carcinoma -- Biomolecular markers for improving management of follicular and medullary thyroid cancer -- Part VII. Hematological cancers. Biomarkers in myelodysplastic syndrome -- Markers for diagnosis, prognosis, and therapy of acute myeloid leukemia -- Biomarkers in Hodgkin's lymphoma -- Multiple myeloma and evolution of novel biomarkers and therapies -- Part VIII. Melanoma. Diagnostic and prognostic biomarkers in cutaneous melanoma
Control code
868928126
Extent
1 online resource (954 pages)
Form of item
online
Isbn
9781466584297
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
Specific material designation
remote
System control number
  • (OCoLC)868928126
  • ebr10821667

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
    • J. Otto Lottes Health Sciences LibraryBorrow it
      1 Hospital Dr, Columbia, MO, 65201, US
      38.939544 -92.328377
Processing Feedback ...